Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer.

Inkoom A, Ndemazie NB, Smith T, Frimpong E, Bulusu R, Poku R, Zhu X, Han B, Trevino J, Agyare E. Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer. BMC Cancer. 2023 May 13; 23(1):435.

View in: PubMed

subject areas

Animals
Cell Line, Tumor
Deoxycytidine
Disease Models, Animal
Humans
Mice
Nanoparticles
Pancreatic Neoplasms
Xenograft Model Antitumor Assays

authors with profiles

Edward Agyare

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support